Target intelligence / Profile preview

Human papillomavirus E1-E2 protein-protein interface (HPV E1-E2 interface)

Target
HPV E1-E2 interface
Molecular classification
Protein-protein interaction site, Other
01

Overview

The **human papillomavirus (HPV) E1-E2 protein-protein interface** is the physical interaction site between the viral E1 and E2 proteins, which cooperate to bind the viral origin of replication (ori), forming the E1-E2-ori complex that is essential for initiating viral DNA replication[1][2][5]. E1 is a viral helicase with DNA-binding and enzymatic (ATPase) activity, while E2 serves primarily as a transcriptional regulator and helps to recruit E1 to the viral origin, enhancing the specificity and efficiency of DNA binding and replication initiation[1][4][5]. Disruption of this protein-protein interface blocks the assembly of the replication complex, thereby inhibiting viral DNA replication, and has been investigated as a potential antiviral approach, especially in the context of diseases linked to persistent HPV infection such as cervical and other anogenital cancers[1][2].

Other names
HPV E1–E2 interfacePapillomavirus E1–E2 complex
02

Mechanism of action

Inhibition of protein-protein interface formation blocks initiation of papillomavirus DNA replication

03

Biological functions

Viral DNA replicationRegulation of viral genome maintenanceRegulation of transcriptionViral proliferation
04

Disease associations

CancerInfection
05

Safety considerations

Targeting viral protein-protein interactions may risk off-target effects in host cells if not highly specificResistance development possible due to viral mutation

Beyond the preview

Go deeper on Human papillomavirus E1-E2 protein-protein interface (HPV E1-E2 interface).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human papillomavirus E1-E2 protein-protein interface (HPV E1-E2 interface).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call